Clinical Trial Update: Relative Bioavailability Study of HR19042 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 relative bioavailability study of HR19042 in healthy subjects has completed. The trial evaluated pharmacokinetics and safety in healthy volunteers, sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis
• Iga Nephropathy

Drugs mentioned

• HR19042

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Primary IgA Nephropathy; Autoimmune Hepatitis | Phase 1 | Status: COMPLETED